Zobrazeno 1 - 10 of 231 pro vyhledávání: '"B Barberio"'
1
Akademický článek
Inflammatory bowel diseases and spondyloarthritis: a focus on female patients
Autor: C. Caranfil, G. Lorenzon, B. Barberio, R. Ramonda, E.V. Savarino, F. Zingone
Publikováno v: Reumatismo, Vol 76, Iss 3 (2024)
Objective. Ulcerative colitis and Crohn’s disease are chronic inflammatory diseases and represent the two most important types of inflammatory bowel diseases (IBD), while spondyloarthritis (SpA) comprises a heterogeneous group of systemic inflammat
Externí odkaz: https://doaj.org/article/75f5953c304f4ca4801b08b69a9210b6
Zobrazit plný text záznamu
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
P674 Ustekinumab is the preferred biological agent in IBD patients with hidradenitis suppurativa failing anti-TNF therapy : results from a real-life multicenter cohort
Autor: B Verstockt ., S Vieujean, M Truyens, M Julsgaard, D Pugliese, D Aslan, M Prokopic, S Lim, C Viganò, S Festa, L Ramos, M J Garciá, R Plaza, D Noviello, E Savarino, D Drobne, N Imperatore, D G Ribaldone, J Van Dongen, N Teich, M Wahed, B Barberio, I Goren
Publikováno v: Journal of Crohn's and Colitis. 17:i805-i806
Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory disease affecting skin that bears apocrine glands and is characterised by painful, deep-seated, inflamed lesions. Treatment includes antibiotics, steroids, surgery, and ada
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dd34222911652c599cbb686bd05e98b6
https://doi.org/10.1093/ecco-jcc/jjac190.0804
Zobrazit plný text záznamu
4
P566 Colitis due to immunotherapy with anti-PD-1: a case series
Autor: M De Ruvo, B Barberio, F Zingone, L Bonanno, A Dal Maso, F Stefano, V Chiarion Sileni, E V Savarino
Publikováno v: Journal of Crohn's and Colitis. 17:i695-i696
Background Anti-programmed death-1 (PD-1) drugs have been associated with immune-mediated gastrointestinal adverse events in 0.5-9% of the cases. The aim of this study was to investigate the characteristics of colitis occurring in oncological patient
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::216fd03403bd34e266d31bb154424912
https://doi.org/10.1093/ecco-jcc/jjac190.0696
Zobrazit plný text záznamu
5
P299 Disability in newly diagnosed patients with Crohn′s Disease: initial results from the prospective CROCO (Crohn′s Disease Cohort) Study
Autor: J Tinoco da Silva Torres, P Ellul, S Vieujean, I Ordas, J Burisch, I Mocanu, D Duricova, I Rodríguez-Lago, A Buisson, A Goldis, V Hernandez, N Arebi, I Kaimakliotis, M Nachury, M Fumery, M Allocca, N Pedersen, B Barberio, S Shaji, A Guedes, R Ribeiro, R Ungaro, J Lambert, J F Colombel
Publikováno v: Journal of Crohn's and Colitis. 17:i443-i444
Background CD is classically seen as a progressive disease leading to bowel damage and disability. Disability has been proposed by the Spirit-IOIBD consensus1 as an endpoint in disease modification trials. However, there is a paucity of data regardin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::302e4e8028250c73ebf281eb7b39b10a
https://doi.org/10.1093/ecco-jcc/jjac190.0429
Zobrazit plný text záznamu
6
P252 Solid organ transplant (with the exception of liver) in patients with inflammatory bowel disease: An ECCO CONFER Multicentre Case Series
Autor: D G Ribaldone, S Vieujean, M Julsgaard, F Zingone, E Savarino, F Cañete, A Aratari, N Imperatore, L Ramos, R Plaza, D Pugliese, B Barberio, D Drobne, M Chaparro
Publikováno v: Journal of Crohn's and Colitis. 17:i403-i404
Background There are limited data available on the course of IBD in patients with solid organ transplantation. The aim of this ECCO CONFER study was to evaluate the trend of IBD before and after solid organ transplantation but liver. Methods This was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4ec470a249568ad1a03fc3455763d7df
https://doi.org/10.1093/ecco-jcc/jjac190.0382
Zobrazit plný text záznamu
7
P542 Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis
Autor: L Cingolani, B Barberio, A Zelante, D Ribaldone, G Testa, L Bertani, A Buda, F Zingone, E V Savarino
Publikováno v: Journal of Crohn's and Colitis. 17:i668-i669
Background Tofacitinib is a small oral molecule approved to treat moderate to severe ulcerative colitis (UC), which effectiveness and safety is still poorly known in UC patients. Recent concerns have been raised regarding its administration at high d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa3e8d30db492c3ac1c7b5f31247969d
https://doi.org/10.1093/ecco-jcc/jjac190.0672
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje